X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (66776) 66776
Newsletter (17082) 17082
Book Review (10044) 10044
Publication (2841) 2841
Newspaper Article (2199) 2199
Book Chapter (285) 285
Magazine Article (238) 238
Conference Proceeding (203) 203
Transcript (146) 146
Book / eBook (68) 68
Reference (52) 52
Dissertation (44) 44
Web Resource (35) 35
Trade Publication Article (28) 28
Paper (6) 6
Streaming Video (5) 5
Journal / eJournal (4) 4
Government Document (3) 3
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (48908) 48908
humans (48483) 48483
non-hodgkin's lymphomas (30598) 30598
male (26787) 26787
female (25640) 25640
middle aged (21238) 21238
adult (18997) 18997
oncology (17367) 17367
aged (16922) 16922
cancer (16477) 16477
non-hodgkins-lymphoma (15913) 15913
research (13137) 13137
hematology (12136) 12136
t cells (10256) 10256
lymphoma, non-hodgkin - pathology (9274) 9274
care and treatment (9166) 9166
chemotherapy (9055) 9055
lymphomas (8809) 8809
lymphoma (8799) 8799
prognosis (8174) 8174
adolescent (7632) 7632
lymphoma, non-hodgkin - drug therapy (6949) 6949
antineoplastic combined chemotherapy protocols - therapeutic use (6678) 6678
animals (6534) 6534
abridged index medicus (6309) 6309
reports (6012) 6012
aged, 80 and over (5982) 5982
treatment outcome (5452) 5452
non-hodgkin's lymphoma (5450) 5450
child (5180) 5180
medical research (4877) 4877
risk factors (4671) 4671
leukemia (4664) 4664
retrospective studies (4642) 4642
rituximab (4575) 4575
lymphoma, non-hodgkin - therapy (4570) 4570
medicine, experimental (4337) 4337
lymphoma, non-hodgkin - diagnosis (4334) 4334
pathology (4239) 4239
health aspects (4238) 4238
analysis (4178) 4178
b-cell lymphoma (4055) 4055
transplantation (3938) 3938
universities and colleges (3932) 3932
diagnosis (3844) 3844
non-hodgkin lymphoma (3569) 3569
therapy (3505) 3505
drug therapy (3329) 3329
disease (3298) 3298
lymphoma, non-hodgkin - complications (3275) 3275
genetic aspects (3273) 3273
neoplasm staging (3181) 3181
non-hodgkin-lymphoma (3171) 3171
combined modality therapy (3143) 3143
immunohistochemistry (3112) 3112
antineoplastic agents - therapeutic use (3042) 3042
diagnosis, differential (3014) 3014
antineoplastic agents (3008) 3008
lymphoma, non-hodgkin (2980) 2980
child, preschool (2979) 2979
tumors (2970) 2970
mice (2916) 2916
immunology (2890) 2890
antimitotic agents (2793) 2793
cyclophosphamide - administration & dosage (2742) 2742
lymphoma, non-hodgkin - immunology (2712) 2712
oncology, experimental (2697) 2697
follow-up studies (2692) 2692
survival (2653) 2653
chronic lymphocytic-leukemia (2646) 2646
expression (2631) 2631
survival rate (2619) 2619
lymphoma, non-hodgkin - mortality (2572) 2572
follicular lymphoma (2493) 2493
survival analysis (2474) 2474
hemic and lymphatic diseases (2457) 2457
young adult (2449) 2449
disease-free survival (2424) 2424
medicine & public health (2420) 2420
malignant-lymphoma (2378) 2378
medicine, general & internal (2364) 2364
lymphoma, non-hodgkin - genetics (2361) 2361
vincristine - administration & dosage (2341) 2341
immunotherapy (2323) 2323
neoplasms (2323) 2323
lymphoma, non-hodgkin - epidemiology (2268) 2268
lymphoma, large b-cell, diffuse - pathology (2224) 2224
biopsy (2222) 2222
classification (2222) 2222
radiotherapy (2217) 2217
apoptosis (2182) 2182
doxorubicin - administration & dosage (2172) 2172
risk (2161) 2161
radiology, nuclear medicine & medical imaging (2134) 2134
time factors (2132) 2132
old medline (2090) 2090
stem cells (2027) 2027
non-hodgkins-lymphomas (2002) 2002
clinical trials (1992) 1992
remission induction (1929) 1929
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (33) 33
Online Resources - Online (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Robarts - Stacks (2) 2
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (80095) 80095
Russian (1210) 1210
French (1043) 1043
Japanese (1000) 1000
German (950) 950
Spanish (573) 573
Chinese (541) 541
Polish (432) 432
Italian (310) 310
Korean (118) 118
Hungarian (114) 114
Czech (111) 111
Portuguese (78) 78
Dutch (44) 44
Bulgarian (42) 42
Croatian (36) 36
Serbian (29) 29
Finnish (25) 25
Turkish (25) 25
Romanian (23) 23
Hebrew (22) 22
Danish (21) 21
Norwegian (18) 18
Slovak (15) 15
Persian (8) 8
Ukrainian (8) 8
Greek (7) 7
Lithuanian (7) 7
Slovenian (3) 3
Swedish (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Galician (1) 1
Indonesian (1) 1
Latvian (1) 1
Manx (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 10/2012, Volume 97, Issue 10, pp. 1594 - 1602
Background In angioimmunoblastic T-cell lymphoma, symptoms linked to B-lymphocyte activation are common, and variable numbers of CD20(+) large B-blasts, often... 
Angioimmunoblastic t-cell lymphoma | Epstein-barr virus | Chop-r | VIRAL LOAD | MULTICENTER | angioimmunoblastic T-cell lymphoma | FOLLICULAR HELPER-CELL | NON-HODGKINS-LYMPHOMAS | PERIPHERAL-BLOOD | REARRANGEMENTS | PREDNISONE | POLYMERASE-CHAIN-REACTION | Epstein-Barr virus | CHOP-R | HEMATOLOGY | EXPRESSION | EPSTEIN-BARR-VIRUS | Doxorubicin - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Immunoblastic Lymphadenopathy - mortality | B-Lymphocytes - virology | Female | Immunoblastic Lymphadenopathy - pathology | B-Lymphocytes - pathology | Prednisone - adverse effects | Rituximab | Immunoblastic Lymphadenopathy - drug therapy | Treatment Outcome | B-Lymphocytes - drug effects | Lymphoma, T-Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell - pathology | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Lymphoma, T-Cell - mortality | Antibodies, Monoclonal, Murine-Derived - pharmacology | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus | Original and Brief Reports
Journal Article
by Howe, A
Western Medical Reformer, 06/1887, Volume xlvii, Issue 6, p. 249
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2011, Volume 153, Issue 5, pp. 582 - 588
Peripheral T‐cell lymphoma (PTCL) has a poorer prognosis than diffuse large B‐cell lymphoma (DLBCL). We administered the CyclOBEAP regimen (cyclophosphamide,... 
peripheral T‐cell lymphoma | prognostic factor | chemotherapy | Prognostic factor | Chemotherapy | Peripheral T-cell lymphoma | peripheral T-cell lymphoma | LADULTE GELA | FEATURES | TRIAL | NM23-H1 EXPRESSION | ETOPOSIDE | NON-HODGKINS-LYMPHOMA | CHOP | DETUDE-DES-LYMPHOMES | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | Doxorubicin - therapeutic use | Prednisolone - adverse effects | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Neoplasm Proteins - metabolism | Cyclophosphamide - adverse effects | NM23 Nucleoside Diphosphate Kinases - metabolism | Cyclophosphamide - therapeutic use | Young Adult | Bleomycin - therapeutic use | Lymphoma, T-Cell, Peripheral - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Prednisolone - therapeutic use | Hematologic Diseases - chemically induced | Lymphoma, T-Cell, Peripheral - drug therapy | Etoposide - adverse effects | Etoposide - therapeutic use | Treatment Outcome | Bleomycin - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Epidemiologic Methods | Vincristine - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Medical research | Care and treatment | Anthracyclines | Cyclophosphamide | Corticosteroids | Medicine, Experimental | Etoposide | Non-Hodgkin's lymphomas | T cells | Prednisolone | Index Medicus | Thrombocytopenia | double prime B-cell lymphoma | Risk groups | biomarkers | Doxorubicin | Survival | Vincristine | Bleomycin | Anaplastic large-cell lymphoma | Age | T-cell lymphoma | Neutropenia
Journal Article
Journal Article
Journal Article
International Journal of Hematology, ISSN 0925-5710, 4/2010, Volume 91, Issue 3, pp. 501 - 508
We report a case of prolonged severe hypogammaglobulinemia after rituximab combined chemotherapy for follicular lymphoma. Although the patient’s globulin level... 
Rituximab | Internal Medicine | Hypogammaglobulinemia | Medicine & Public Health | Hematology | Lymphoma class-switch | IMMUNOGLOBULIN | COMMON VARIABLE IMMUNODEFICIENCY | SUBSET | ADJUVANT | THERAPY | INDOLENT LYMPHOMA | NON-HODGKINS-LYMPHOMA | STEM-CELL TRANSPLANTATION | HEMATOLOGY | EXPRESSION | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Agammaglobulinemia - pathology | Agammaglobulinemia - drug therapy | T-Lymphocytes - drug effects | Doxorubicin - analogs & derivatives | Vincristine - administration & dosage | Female | B-Lymphocytes - pathology | Homeostasis - drug effects | T-Lymphocytes - pathology | Doxorubicin - administration & dosage | Granulocyte Colony-Stimulating Factor - adverse effects | Severity of Illness Index | Prednisone - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Prednisone - adverse effects | Lymphoma, Follicular - pathology | Homeostasis - immunology | Immunophenotyping | Bleomycin - administration & dosage | Bleomycin - adverse effects | B-Lymphocytes - drug effects | Cell Differentiation - immunology | Procarbazine - adverse effects | Antibodies, Monoclonal - administration & dosage | Cell Differentiation - drug effects | Vincristine - adverse effects | Doxorubicin - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Apoptosis | Index Medicus
Journal Article
AIDS, ISSN 0269-9370, 01/2011, Volume 25, Issue 2, pp. 274 - 275
A recent article by Engels et al. [1] published in the Lancet Oncology concludes that persons with hepatitis B virus (HBV) are at greater risk of developing... 
INFECTIOUS DISEASES | NON-HODGKINS-LYMPHOMA | COHORT | VIROLOGY | IMMUNOLOGY
Journal Article
Journal Article
International Journal of Hematology, ISSN 0925-5710, 11/2010, Volume 92, Issue 4, pp. 617 - 623
Journal Article
Advances in Therapy, ISSN 0741-238X, 4/2011, Volume 28, Issue 4, pp. 304 - 310
Mobilization techniques for autologous peripheral blood stem cell (PBSC) collection include chemotherapy followed by hematopoietic growth factors, such as... 
hematological malignancies | stem cell mobilization | Rheumatology | Oncology | Internal Medicine | G-CSF | leukapheresis | autologous transplantation | Medicine & Public Health | Zarzio | biosimilars | Cardiology | Pharmacology/Toxicology | Endocrinology | Biosimilars | Leukapheresis | Autologous transplantation | Stem cell mobilization | Hematological malignancies | MULTIPLE-MYELOMA | MEDICINE, RESEARCH & EXPERIMENTAL | COLLECTION | FILGRASTIM | CHEMOTHERAPY | BREAST-CANCER | LUNG-CANCER | FEBRILE NEUTROPENIA | NON-HODGKINS-LYMPHOMA | PHARMACOLOGY & PHARMACY | XM02 | Granulocyte Colony-Stimulating Factor - adverse effects | Hematologic Neoplasms - therapy | Hematopoietic Stem Cell Mobilization - standards | Peripheral Blood Stem Cell Transplantation - methods | Hematopoietic Stem Cell Mobilization - methods | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols | Male | Treatment Outcome | Antineoplastic Agents - administration & dosage | Recombinant Proteins | Transplantation, Autologous - methods | Leukapheresis - standards | Filgrastim | Granulocyte Colony-Stimulating Factor - pharmacokinetics | Antineoplastic Agents - adverse effects | Injections, Subcutaneous | Adult | Female | Aged | Antineoplastic Agents - pharmacokinetics | Research Design | Granulocyte Colony-Stimulating Factor - administration & dosage | Chemotherapy | Biological products | Granulocyte colony-stimulating factor | Stem cells | Transplantation | Macrophage colony stimulating factor | Hematopoietic stem cells | Cancer | Health technology assessment
Journal Article